Advertisement
Document › Details
Sysmex Inostics GmbH. (6/17/20). "Press Release: New CEO & President at Sysmex Inostics GmbH". Hamburg.
Organisation | Sysmex Inostics GmbH | |
Group | Sysmex (Group) | |
Organisation 2 | Eppendorf AG | |
Today | Eppendorf SE | |
Group | Eppendorf (Group) | |
Product | OncoBEAM™ test (blood-based oncology test) | |
Product 2 | SafeSEQ technology (NGS) | |
Person | Agrawal, Bhuwnesh (Sysmex 202004– Managing Director (CEO) of Sysmex Inostics GmbH before Eppendorf + Vela Dx + Roche) | |
As of April 1st, 2020, Dr. Bhuwnesh Agrawal started as new CEO & President at Sysmex Inostics GmbH.
Dr. Bhuwnesh Agrawal brings a broad background with his medical and industry experience extending over 4 decades from R&D to strategy, business development, marketing and sales. In his new position at Sysmex Inostics GmbH, he will focus on the strategic development of the liquid biopsy business, especially R&D.
Sysmex Inostics, a subsidiary of Sysmex Corporation is a molecular diagnostics company that is a pioneer in blood-based cell-free tumor DNA testing in oncology. We are a trusted partner to leading pharmaceutical companies, advancing their efforts to bring the most effective personalized cancer therapies and solutions to global markets.
Our highly sensitive OncoBEAM™ (BEAMing) digital PCR and SafeSEQ (Next Generation Sequencing) technologies can detect minute amounts of mutant DNA circulating in the bloodstream to identify gene mutations and improve the characterization of tumors. With these technologies we support clinical researchers and oncologists with therapy selection and monitoring of response, recurrence as well as resistance.
Today, Sysmex Inostics supports its customers with tailored assay solutions which fit the individual study design, provides new assays for clinical applications in oncology and offers global services for pharmaceutical companies – from discovery to companion diagnostics.
For more information refer to www.sysmex-inostics.com or email info@sysmex-inostics.com
Contact:
Sysmex Inostics
Press Release
Phone: +49-(0)-40-3259070
Mail: info@sysmex-Inostics.com
Record changed: 2023-06-05 |
Advertisement
More documents for Sysmex (Group)
- [1] SAFIA Technologies GmbH. (2/15/24). "Press Release: Sysmex Partec and SAFIA Technologies. Pioneering Mycotoxin Analysis". Görlitz & Berlin....
- [2] Oxford Gene Technology Ltd.. (4/4/22). "Press Release: OGT Welcomes Adrian Smith as CEO". Oxford....
- [3] bioMérieux S.A.. (7/27/17). "Press Release: Sysmex and bioMérieux Agreed to Dissolve the Joint Venture Sysmex bioMérieux Co., Ltd.". Kobe & Marcy l'Etoile....
- [4] Sysmex Corporation. (5/31/17). "Press Release: Sysmex Acquires UK Company to Expand into New Business Domains toward Personalized Medicine"....
- [5] Oxford Gene Technology Ltd.. (5/31/17). "Press Release: OGT to Be Acquired by Sysmex Corporation". Oxford....
- [6] Biocartis Group N.V.. (4/4/17). "Press Release: Biocartis Establishes US Subsidiary and Appoints US General Manager". Mechelen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top